NIH’s Convalescent Plasma Emergency Department Clinical Trial Halted by Data Safety Monitoring Board
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) has halted a clinical […]
Drug Known as Proxalutamide Accelerates COVID-19 Viral Clearance While Reducing Time to Clinical Remission
A joint American and Brazilian team recently studied a drug called proxalutamide as a treatment for COVID-19. A nonsteroidal antiandrogen […]
Mexican Sponsored Study Reveals Sulodexide Positively Impacts Progression of COVID-19 Disease Progression
A randomized, placebo-controlled study led by researchers from Mexico involving 243 patients led to the conclusion of investigators that supports […]
Peer-Reviewed: Randomized Controlled Trial in Nigeria Shows Ivermectin Exhibits Positive Clinical Benefit in Mild to Moderate COVID-19
TrialSite recently introduced the Nigerian-based IVERCOVID study. In an interview with the principal investigator Professor Olufemi Babalola, an ophthalmologist and […]
Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology
Back in May 2020, TrialSite announced the study titled a pilot clinical trial led by Egypt’s Mansoura University, located in […]
Calcifediol Treatment for COVID-19 at Hospitalization Reduces ICU Admission & Mortality According to Spanish Study
Recently, Xavier Nogués from the Autonomous University of Barcelona Department of Medicine and other prominent Spanish academic medical centers recently […]
Large Dominican Real World Observational Study with Compassionate Ivermectin Use Points to Strong Efficacy Signal
Researchers from health systems conducted a retrospective observational study out of the Dominican Republic, a nation that has been using […]
Gamida Cell Presents Omidubicel Phase 3 Data in Patients with High-Risk Hematologic Malignancies
Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]
ArvoBio Gene Therapy Trials Successful Across Three Different Rare Lysosomal Diseases: Fabry, Gaucher type 1 and Cystinosis
ARVOBIO presented results from three ongoing clinical trials evaluating its lentiviral gene therapies: a phase II study assessing AVR-RD-01 for […]
PaxMedica Announces Efficacy of PAX-101 (IV suramin) in Reducing Core Symptoms of Autism Spectrum Disorder
PaxMedica announced positive results from a phase 2 dose-ranging clinical trial evaluating PAX-124890-=101 demonstrated sustained improvements over placebo in the […]
